USA - NYSE:RZC - US7593518852
The current stock price of RZC is 25.48 USD. In the past month the price decreased by -0.39%. In the past year, price decreased by -4.46%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| RGA | REINSURANCE GROUP OF AMERICA | 8.68 | 12.47B | ||
| RZB | REINSURANCE GRP OF AMER - RGA 5 3/4 06/15/56 | 1.15 | 1.65B |
Reinsurance Group of America, Inc. is a holding company, which engages in the provision of traditional and non-traditional life and health reinsurance products. The company is headquartered in Chesterfield Missouri, Missouri and currently employs 4,100 full-time employees. The firm is a provider of traditional life and health reinsurance and financial solutions. The U.S. and Latin America Traditional segment provides individual and group life and health reinsurance, including long-term care, to domestic clients for a variety of products. The Canada Traditional segment is primarily engaged in individual life reinsurance, and to a lesser extent creditor, group life and health, critical illness and disability reinsurance. The Europe, Middle East and Africa Traditional segment provides individual and group life and health products through yearly renewable term and coinsurance agreements, and reinsurance of critical illness coverage. The Asia Pacific Traditional segment provides individual and group life and health reinsurance, critical illness coverage, disability and superannuation through yearly renewable term and coinsurance agreements.
REINSURANCE GRP OF AMER - RGA 7 1/8 10/15/52
16600 Swingley Ridge Road
Chesterfield Missouri MISSOURI US
Employees: 4100
Phone: 16367367000
Reinsurance Group of America, Inc. is a holding company, which engages in the provision of traditional and non-traditional life and health reinsurance products. The company is headquartered in Chesterfield Missouri, Missouri and currently employs 4,100 full-time employees. The firm is a provider of traditional life and health reinsurance and financial solutions. The U.S. and Latin America Traditional segment provides individual and group life and health reinsurance, including long-term care, to domestic clients for a variety of products. The Canada Traditional segment is primarily engaged in individual life reinsurance, and to a lesser extent creditor, group life and health, critical illness and disability reinsurance. The Europe, Middle East and Africa Traditional segment provides individual and group life and health products through yearly renewable term and coinsurance agreements, and reinsurance of critical illness coverage. The Asia Pacific Traditional segment provides individual and group life and health reinsurance, critical illness coverage, disability and superannuation through yearly renewable term and coinsurance agreements.
The current stock price of RZC is 25.48 USD. The price increased by 0.08% in the last trading session.
REINSURANCE GRP OF AMER - RGA 7 1/8 10/15/52 (RZC) has a dividend yield of 1.95%. The yearly dividend amount is currently 3.48.
RZC has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
RZC stock is listed on the New York Stock Exchange, Inc. exchange.
15 analysts have analysed RZC and the average price target is 32.41 USD. This implies a price increase of 27.2% is expected in the next year compared to the current price of 25.48.
The outstanding short interest for REINSURANCE GRP OF AMER - RGA 7 1/8 10/15/52 (RZC) is 0.08% of its float.
ChartMill assigns a technical rating of 1 / 10 to RZC. When comparing the yearly performance of all stocks, RZC is a bad performer in the overall market: 66.85% of all stocks are doing better.
ChartMill assigns a fundamental rating of 4 / 10 to RZC. RZC has a bad profitability rating. Also its financial health evaluation is rather negative.
Over the last trailing twelve months RZC reported a non-GAAP Earnings per Share(EPS) of 21.74. The EPS decreased by -2.77% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 3.89% | ||
| ROA | 0.57% | ||
| ROE | 6.68% | ||
| Debt/Equity | 0.44 |
15 analysts have analysed RZC and the average price target is 32.41 USD. This implies a price increase of 27.2% is expected in the next year compared to the current price of 25.48.
For the next year, analysts expect an EPS growth of -3.8% and a revenue growth 2.94% for RZC